MADRID, June 3, 2010 /PRNewswire/ -- Zimmer Holdings, Inc. , a leader in musculoskeletal care, will be showcasing its extended Acetabular Cup portfolio at this year's EFORT (European Federation of National Associations of Orthopaedics and Traumatology) Congress in Madrid, Spain. The recently launched Zimmer Allofit(R) IT, Continuum(TM) and Trilogy(R) IT Systems incorporate proven fixation technologies and an integrated taper design that give surgeons the ability to choose from a range of bearing options to better match the demands of individual patients.

Providing a more personalized fit to patients and increasing range of motion are key points of emphasis in our acetabular offerings, said Katarzyna Mazur, Senior Vice President, Sales and Marketing, EMEA and General Manager, Zimmer GmbH. The versatile nature of our Acetabular Cup portfolio incorporates multiple cup liners to provide surgeons with the cup and bearing options that best fit their individual patients' anatomy and lifestyles.

Hip replacement surgery patients represent diverse age groups and lifestyles. As a result, surgeons need to consider a variety of implant bearings to accommodate their patients' needs. Zimmer's 3-in-1 system of bearing options is applicable for a wide range of clinical indications. The Metasul(R) Liner incorporates Zimmer's Metasul Metal-on-Metal Technology which provides stability and low wear and has more than twenty years of successful clinical history. Longevity(R) Highly Crosslinked Polyethylene, the principal technology behind the polyethylene liner, is highly resistant to wear and aging with more than ten years of clinical experience. BIOLOX(R) delta Ceramic Liner Technology provides excellent biocompatibility, low wear, high hardness and good mechanical performance.

The Continuum Cup, recently launched globally, is made with Zimmer's Trabecular Metal(TM) Technology, a highly porous tantalum material that supports initial stability and long term biologic fixation. The Trilogy IT Cup builds on the success of the Harris/Galante(TM) Porous and HGP II Cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene debris.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2009 sales were approximately US$4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit http://www.zimmer.com

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as may, will, expects, believes, anticipates, plans, estimates, projects, assumes, guides, targets, forecasts, and seeks or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE: Zimmer Holdings, Inc.

CONTACT: Media, Sabine Ciccotosto, +41(0)52-262-72-41,sabine.ciccotosto@zimmer.com; Investors: Paul Blair, +1-574-371-8042,paul.blair@zimmer.com; James T. Crines, +1-574-372-4264,james.crines@zimmer.com